Enables integrin binding activity; platelet-derived growth factor binding activity; and protease binding activity. An extracellular matrix structural constituent. Involved in several processes, including cell surface receptor signaling pathway; collagen fibril organization; and peptide cross-linking. Located in collagen-containing extracellular matrix and extracellular space. Part of collagen type III trimer. Implicated in Ehlers-Danlos syndrome; Ehlers-Danlos syndrome hypermobility type; end stage renal disease; and vascular type Ehlers-Danlos syndrome.
alpha-1 type III collagen; alpha1 (III) collagen; collagen alpha-1(III) chain; collagen type III alpha 1; collagen, fetal; collagen, type III, alpha 1; EDS4A; EDSVASC; Ehlers-Danlos syndrome type IV, autosomal dominant; FLJ34534; PMGEDSV
[Citrinin co-treated with ochratoxin A] results in decreased expression of COL3A1 mRNA and [Citrinin co-treated with ochratoxin A] results in increased expression of and results in increased secretion of COL3A1 protein
[Oxygen deficiency results in increased susceptibility to epigallocatechin gallate] which results in decreased expression of COL3A1 mRNA and epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased expression of COL3A1 mRNA]
Colchicine inhibits the reaction [Carbon Tetrachloride results in increased expression of and results in increased secretion of COL3A1 protein] and Colchicine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL3A1 mRNA]
AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of COL3A1 mRNA] and Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of COL3A1 mRNA]
Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA] and Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]
CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein] and Valsartan inhibits the reaction [Glucose results in increased expression of COL3A1 protein]
[bisphenol F co-treated with Tretinoin] results in decreased expression of COL3A1 mRNA and [bisphenol S co-treated with Tretinoin] results in decreased expression of COL3A1 mRNA
acetovanillone inhibits the reaction [AGT protein results in increased expression of COL3A1 mRNA] and acetovanillone inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of COL3A1 mRNA] and fulvestrant inhibits the reaction [bisphenol A results in increased expression of COL3A1 mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with Dietary Fats] results in increased expression of COL3A1 mRNA more ...
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with Dietary Fats] results in increased expression of COL3A1 mRNA more ...
Captopril inhibits the reaction [AGT protein results in increased expression of COL3A1 protein] and Captopril inhibits the reaction [Silicon Dioxide results in increased expression of COL3A1 protein]
Carnosine inhibits the reaction [ALB protein modified form results in increased expression of COL3A1 mRNA] and Carnosine inhibits the reaction [Norepinephrine results in increased expression of COL3A1 mRNA]
CTNNB1 protein affects the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine results in increased expression of COL3A1 protein]
[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL3A1 mRNA more ...
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA more ...
[Chelating Agents binds to Copper] which results in decreased expression of COL3A1 mRNA and [Disulfiram binds to Copper] which results in increased expression of COL3A1 mRNA
[Chelating Agents binds to Copper] which results in decreased expression of COL3A1 mRNA and [Disulfiram binds to Copper] which results in increased expression of COL3A1 mRNA
CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein] and Valsartan inhibits the reaction [Glucose results in increased expression of COL3A1 protein]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA
[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein and Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA
[Oxygen deficiency results in increased susceptibility to epigallocatechin gallate] which results in decreased expression of COL3A1 mRNA and epigallocatechin gallate inhibits the reaction [Oxygen deficiency results in increased expression of COL3A1 mRNA]
[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein and Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein]
Dipyridamole inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA] and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dipyridamole inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]]
Dizocilpine Maleate inhibits the reaction [Excitatory Amino Acid Agonists results in increased expression of COL3A1 mRNA] and U 0126 inhibits the reaction [Excitatory Amino Acid Agonists results in increased expression of COL3A1 mRNA]
Fenofibrate inhibits the reaction [AHR protein affects the reaction [AGT protein results in increased expression of COL3A1 mRNA]] and Fenofibrate inhibits the reaction [Zoledronic Acid results in increased expression of COL3A1 mRNA]
[NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA and [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of COL3A1 mRNA
Genistein inhibits the reaction [Ethanol results in increased expression of COL3A1 protein] and Genistein inhibits the reaction [Galactosamine results in increased expression of COL3A1 mRNA]
CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein] and Valsartan inhibits the reaction [Glucose results in increased expression of COL3A1 protein]
[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of COL3A1 mRNA
[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of COL3A1 mRNA
[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL3A1 mRNA more ...
Losartan inhibits the reaction [AGT protein results in increased expression of COL3A1 protein] and Losartan promotes the reaction [ICG 001 inhibits the reaction [AGT protein results in increased expression of COL3A1 protein]]
Losartan inhibits the reaction [AGT protein results in increased secretion of COL3A1 protein] and Losartan inhibits the reaction [Paraquat results in increased expression of COL3A1 protein]
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL3A1 mRNA
LIPA affects the reaction [morroniside inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]] and morroniside inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Dipyridamole inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA]]
[Citrinin co-treated with ochratoxin A] results in decreased expression of COL3A1 mRNA and [Citrinin co-treated with ochratoxin A] results in increased expression of and results in increased secretion of COL3A1 protein
[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which affects the expression of COL3A1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of COL3A1 mRNA
Ambroxol affects the reaction [Paraquat results in increased expression of COL3A1 mRNA] and Losartan inhibits the reaction [Paraquat results in increased expression of COL3A1 protein]
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL3A1 mRNA
plantamajoside inhibits the reaction [Isoproterenol results in increased expression of COL3A1 mRNA] and plantamajoside inhibits the reaction [Isoproterenol results in increased expression of COL3A1 protein]
salvianolic acid A affects the reaction [[Streptozocin co-treated with [APOE protein affects the susceptibility to Dietary Fats]] affects the expression of COL3A1 mRNA]
Poly G inhibits the reaction [Silicon Dioxide results in increased expression of COL3A1 mRNA] and Poly G inhibits the reaction [Silicon Dioxide results in increased expression of COL3A1 protein]
Spironolactone results in decreased expression of COL3A1 protein alternative form and Spironolactone results in decreased expression of COL3A1 protein modified form
[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL3A1 mRNA and Testosterone inhibits the reaction [Dexamethasone results in decreased expression of COL3A1 mRNA]
1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea inhibits the reaction [Carbon Tetrachloride results in increased expression of COL3A1 mRNA] more ...
[4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid co-treated with Carbon Tetrachloride] results in increased expression of COL3A1 protein more ...
NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL3A1 protein]] and tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL3A1 protein]
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL3A1 mRNA
Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 mRNA] and Verapamil inhibits the reaction [TGFB1 protein results in increased expression of COL3A1 protein]
[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein and Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein]
[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of COL3A1 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of COL3A1 mRNA
Fenofibrate inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA] and SLC27A2 gene mutant form inhibits the reaction [zoledronic acid results in increased expression of COL3A1 mRNA]